james lampkin1 Risperdal plaintiff granted retrial against J&J, Janssen PharmaceuticalsLast month the Superior Court of Pennsylvania granted a young man’s motion for retrial against pharmaceutical giant Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, the maker of the anti-psychotic drug Risperdal, according to PennRecord. By granting the retrial, the court reversed the only Risperdal jury verdict that had been handed down in favor of the defendants.

Like thousands of other plaintiffs, W.C. alleges the defendants didn’t adequately warn about the risk of gynecomastia (female-like breast development) in adolescent males taking Risperdal. During the trial, a physician’s assistant, Michelle Baker, testified about helping treat W.C. The appeals court said that Baker’s testimony was erroneously allowed to cross the line from fact to expert by the Philadelphia Court of Common Pleas.

The appellate court determined that Baker was testifying as an expert when she opined on what caused W.C.’s gyneomastia. Before she testified, her opinion had not received the level of scrutiny required of witnesses testifying as experts. The determination served as a basis for granting a retrial.

W.C. was prescribed Risperdal to treat oppositional defiant disorder. As Beasley Allen has previously explained, the Food and Drug Administration (FDA) initially approved the drug in 1994 to treat schizophrenia in adult patients. It has since been approved to treat adolescent schizophrenia, bipolar mania in adults and children ages 10 to 17, and symptoms of autism in children and adolescents ages 5 to 17.

The Jere Beasley Report describes how Janssen aggressively marketed the drug for off-label uses in children and adolescents from 1998 to at least 2004. In 2013, Johnson & Johnson agreed to a $2.2-billion settlement with the U.S. Department of Justice (DOJ) over these and other deceptive marketing practices involving Risperdal.

At least five Risperdal plaintiffs have won their cases and verdicts have been awarded ranging from $500,0000 to $77 million, according to Drugwatch.com. Approximately 5,500 claims have been filed against the defendants in the Philadelphia County Court of Common Pleas and its Complex Litigation Center. Three thousand of those lawsuits were filed between January and March of this year. In addition to the Pennsylvania cases, approximately 16,900 lawsuits have been filed over the antipsychotic drug nationwide, according to LawyersandSettlements.com.

* * *

If you or a loved one has been diagnosed with gynecomastia as a result of taking Risperdal, contact James Lampkin, a lawyer in our firm’s Mass Torts Section, at 800-898-2034 or by email at James.Lampkin@beasleyallen.com.

Sources:
PennRecord
Beasley Allen
Jere Beasley Report (October 2012)
Drugwatch.com
LawyersandSettlements.com



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Risperdal Side Effects

New York man awarded $1M in Risperdal gynecomastia...

Risperdal has been linked to a condition called gynecomastia, in which males grow female-like breasts....
Risperdal Side Effects

No new trial for Janssen Pharmaceutical in $2.5...

The company was seeking a new trial as part of an effort to overturn a $2.5 million jury verdict that...
Risperdal Side Effects

Risperdal legal troubles continue to mount

The suit was filed by a number of child advocacy organizations on behalf of children in the Missouri...
Risperdal Side Effects

Johnson & Johnson, Janssen Pharmaceuticals legal...

Plaintiffs contend Janssen concealed the risk of Risperdal’s most devastating side effect,...
Beasley Allen New Principals Announced for 2015, David Dearing, Danielle Ward-Mason, Matt Teague and James Lampkin

Beasley Allen names Dearing, Mason, Teague and Lampkin...

Beasley Allen has named four attorneys as new Principals: David Dearing, James Lampkin, Danielle Ward...
Risperdal Side Effects

Risperdal side effects include breast development in...

Risperdal, also known as risperidone, has been linked to a condition known as gynecomastia,...

Thank you for all your hard work

Thank you for all your hard work over the past years on my behalf and so many others. God bless you all.

—Ella